CN1094620A - The Chinese patent medicine Liu Hua ai huixiangdan of the treatment esophageal carcinoma - Google Patents
The Chinese patent medicine Liu Hua ai huixiangdan of the treatment esophageal carcinoma Download PDFInfo
- Publication number
- CN1094620A CN1094620A CN93104343A CN93104343A CN1094620A CN 1094620 A CN1094620 A CN 1094620A CN 93104343 A CN93104343 A CN 93104343A CN 93104343 A CN93104343 A CN 93104343A CN 1094620 A CN1094620 A CN 1094620A
- Authority
- CN
- China
- Prior art keywords
- radix
- patent medicine
- chinese patent
- treatment
- esophageal carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 208000017897 Carcinoma of esophagus Diseases 0.000 title claims abstract description 13
- 206010030155 Oesophageal carcinoma Diseases 0.000 title claims abstract description 13
- 201000005619 esophageal carcinoma Diseases 0.000 title claims abstract description 13
- 241000124079 Mylabris Species 0.000 claims abstract description 11
- 241000131808 Scolopendra Species 0.000 claims abstract description 11
- 241000239226 Scorpiones Species 0.000 claims abstract description 11
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims abstract description 11
- 241000237903 Hirudo Species 0.000 claims abstract description 10
- 241000208340 Araliaceae Species 0.000 claims abstract description 8
- 241001312741 Gekko swinhonis Species 0.000 claims abstract description 8
- 244000153234 Hibiscus abelmoschus Species 0.000 claims abstract description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 8
- 235000008434 ginseng Nutrition 0.000 claims abstract description 8
- 239000003998 snake venom Substances 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 8
- 238000009472 formulation Methods 0.000 claims description 6
- 238000003809 water extraction Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 231100000614 poison Toxicity 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 230000007096 poisonous effect Effects 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 4
- 235000008216 herbs Nutrition 0.000 abstract description 3
- 230000036737 immune function Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 239000003440 toxic substance Substances 0.000 abstract description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 2
- 208000026435 phlegm Diseases 0.000 abstract description 2
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000003672 processing method Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A kind of Chinese patent medicine for the treatment of the esophageal carcinoma; the remission rate of the existing treatment by Chinese herbs esophageal carcinoma only 10-40%; this Chinese medicine adopts treating the poisonous disease with poisonous drugs; heat-clearing and toxic substances removing; dissipating phlegm and resolving masses; the Therapeutic Principle of the body resistance strengthening and constitution consolidating; select arsenicum sablimatum for use; Mylabris; Venenum Bufonis; snake venom; Scolopendra; Hirudo; the scorpion tail; Gekko Swinhonis; Moschus; Calculus Bovis; Radix Adenophorae (Radix Glehniae); Radix Ginseng; Radix Pseudostellariae; 14 flavor Chinese medicines such as Cornu Cervi Degelatinatum are made patent medicine; after taking, the patient can effectively kill and wound cancerous cell; strengthen immune function of human body; improve the symptom that the middle and advanced stage patient can not take food; improve the human body resistance against diseases; clinical effective rate reaches 67.59%, takes this medicine simultaneously and does not have obvious toxic-side effects, and is safe and reliable.
Description
The invention belongs to a kind of Chinese patent medicine for the treatment of the esophageal carcinoma.
The esophageal carcinoma is one of common cancer, and mortality rate is higher, and serious harm human life health except that symptomatic treatment, is gone back inefficacy Chinese patent medicine preferably at present.The nearly curative effect of traditional Chinese medicine on esophageal carcinoma during the last ten years obtains certain progress, but show according to the documents and materials statistics, simple remission rate with the treatment by Chinese herbs esophageal carcinoma only can reach 10-40%(and see " Chinese and Western is in conjunction with the oncology " 1989.12 P400-425 pages or leaves), as seen curative effect can not be satisfactory, generally also have simultaneously a problem in esophageal carcinoma therapy: the middle and advanced stage patient is owing to can not take food, cause physical weakness, also influenced therapeutic effect greatly.
The present invention aims to provide the very fast reduction of patient disease of a kind of energy, improve himself resistance against diseases and obtain the pure Chinese medicinal preparation of the treatment esophageal carcinoma of higher curative effect.
The object of the present invention is achieved like this: dosage and the formulation ratio of 100 days each courses of treatment of this Chinese patent medicine are:
Arsenicum sablimatum 9-12g Venenum Bufonis 28-31g snake venom 13-16g
49 Hirudo 85-93g of Mylabris 28-31g Scolopendra
Scorpion tail 12-17g Gekko Swinhonis 200-250g Moschus 1-3g
Calculus Bovis 1g Radix Adenophorae (Radix Glehniae) 100-130g Radix Ginseng 200-250g
Radix Pseudostellariae 200-250g Cornu Cervi Degelatinatum 25-32g
Arsenicum sablimatum wherein, Scolopendra, Hirudo, scorpion tail, Radix Adenophorae (Radix Glehniae) be all earlier through with the processing of water extraction, and Mylabris is earlier through traditional liter refining processing, again with above-mentioned various compositions traditional method decocting, concentrated make Powdered.
We have adopted the prescription therapeutic principle of " treating the poisonous disease with poisonous drugs ", " heat-clearing and toxic substances removing ", " dissipating phlegm and resolving masses ", " the body resistance strengthening and constitution consolidating "; but as the Mylabris in the side, Venenum Bufonis, scorpion tail, Scolopendra, Gekko Swinhonis, arsenicum sablimatum treating the poisonous disease with poisonous drugs, kill and wound cancerous cell; Calculus Bovis, Moschus heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling; Radix Ginseng, Radix Pseudostellariae, Cornu Cervi Degelatinatum strengthening vital QI to eliminate pathogenic factors increase immunologic function.
The part Chinese materia medica tocixity of selecting for use among the we is bigger, in order to reduce its toxicity, and guarantees that fully it kills and wounds the effect of cancerous cell, and this class medicine all through rising processing such as refining or water extraction concentrate, greatly reduces its toxicity, has guaranteed the safety to human body.This medicine is through acute poison test, give 10 white mice dosing times by people's dose 104 multiple doses, observe and do not have death in 6 days, through routine clinical trial surplus in the of 4500 more than 3 years, find no obvious toxic-side effects, and 60% middle and advanced stage patient medication can improve symptom in 7-15 days, became smooth feed by not taking food.
" tumor efficiency common index " with reference to the whole nation " Chinese and Western is in conjunction with the tumor academic conference " in December, 1979 formulation is foundation, 108 routine patient with esophageal carcinoma have been made the clinical efficacy statistical procedures, clinical symptoms is alleviation person's 50 examples fully, part alleviation person 23 examples, and total effective rate is 67.59%.Through 54 of this group patients are followed up a case by regular visits to, above patient's 11 examples of a year and a half of surviving, existence patient's 15 examples more than a year, existence patient's 21 examples more than 6 months, existence patient's 7 examples more than 3 months, mean survival time (MST), prolong 9.6 months, and this medicine also has better curative effect to other digestive tract cancer.
This Chinese medicine can effectively kill and wound cancerous cell, strengthen patient's immunologic function simultaneously, improve the situation that the middle and advanced stage patient can not take food, improve the resistance against diseases of human body, thereby make clinical effective rate reach 67.59%, considerably beyond the average effectiveness level of present other treatment by Chinese herbs esophageal carcinoma, this medicine can also on average prolong survival time of patients more than 9 months, and take this medicine and do not have obvious toxic-side effects, safe and reliable.
The invention will be further described below in conjunction with embodiment.
Embodiment 1: " the Liu Shiization cancer is rejuvenated red " by dosage 100 days per courses of treatment, its proportioning prescription is:
Arsenicum sablimatum 10g Venenum Bufonis 30g snake venom 15g
49 Hirudo 90g of Mylabris 30g Scolopendra
Scorpion tail 15g Gekko Swinhonis 240g Moschus 2g
Calculus Bovis 1g Radix Adenophorae (Radix Glehniae) 120g Radix Ginseng 240g
Radix Pseudostellariae 240g Cornu Cervi Degelatinatum 30g
With arsenicum sablimatum, Scolopendra, Hirudo, scorpion tail, Radix Adenophorae (Radix Glehniae) water extraction wherein, Mylabris is processed with traditional smelting method that rises, again with mentioned component medicine water boiling concentration, refinement, finally making the about 420g of powdered drug packs in 1200 capsules, every about 0.35 gram, every day three times when taking, each four, 100 days courses of treatment.
Embodiment 2: by dosage 100 days per courses of treatment, its formulation ratio is:
Arsenicum sablimatum 9g Venenum Bufonis 28g snake venom 13g
49 Hirudo 85g of Mylabris 28g Scolopendra
Scorpion tail 12g Gekko Swinhonis 200g Moschus 1g
Calculus Bovis 1g Radix Adenophorae (Radix Glehniae) 100g Radix Ginseng 200g
Radix Pseudostellariae 200g Cornu Cervi Degelatinatum 25g
Processing method is the same.
Embodiment 3: by dosage 100 days per courses of treatment, its formulation ratio is:
Arsenicum sablimatum 12g Venenum Bufonis 31g snake venom 16g
Mylabris 31g Scolopendra 49g Hirudo 93g
Scorpion tail 17g Gekko Swinhonis 250g Moschus 3g
Calculus Bovis 1g Radix Adenophorae (Radix Glehniae) 130g Radix Ginseng 250g
Radix Pseudostellariae 240g Cornu Cervi Degelatinatum 32g
Processing method is the same.
Claims (2)
1, a kind of Chinese patent medicine for the treatment of the esophageal carcinoma is characterized in that: dosage and the formulation ratio of 100 days each courses of treatment of described Chinese patent medicine are:
Arsenicum sablimatum 9-12g Venenum Bufonis 28-31g snake venom 13-16g
49 Hirudo 85-93g of Mylabris 28-31g Scolopendra
Scorpion tail 12-17g Gekko Swinhonis 200-250g Moschus 1-3g
Calculus Bovis 1g Radix Adenophorae (Radix Glehniae) 100-130g Radix Ginseng 200-250g
Radix Pseudostellariae 200-250g Cornu Cervi Degelatinatum 25-32g
Arsenicum sablimatum wherein, Scolopendra, Hirudo, scorpion tail, Radix Adenophorae (Radix Glehniae) be all earlier through with the processing of water extraction, and Mylabris is earlier through traditional liter refining processing, again with the various compositions of above-mentioned prescription traditional method decocting, concentrated make Powdered.
2, Chinese patent medicine as claimed in claim 1 is characterized in that: dosage and the formulation ratio of 100 days each courses of treatment of described Chinese patent medicine are:
Arsenicum sablimatum 10g Venenum Bufonis 30g snake venom 15g
49 Hirudo 90g of Mylabris 30g Scolopendra
Scorpion tail 15g Gekko Swinhonis 240g Moschus 2g
Calculus Bovis 1g Radix Adenophorae (Radix Glehniae) 120g Radix Ginseng 240g
Radix Pseudostellariae 240g Cornu Cervi Degelatinatum 30g
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93104343A CN1050045C (en) | 1993-04-17 | 1993-04-17 | Traditional Chinese medicine-Liu's Hua'ai huixiangdan for treating carcinoma of esophagus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93104343A CN1050045C (en) | 1993-04-17 | 1993-04-17 | Traditional Chinese medicine-Liu's Hua'ai huixiangdan for treating carcinoma of esophagus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1094620A true CN1094620A (en) | 1994-11-09 |
| CN1050045C CN1050045C (en) | 2000-03-08 |
Family
ID=4985145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93104343A Expired - Fee Related CN1050045C (en) | 1993-04-17 | 1993-04-17 | Traditional Chinese medicine-Liu's Hua'ai huixiangdan for treating carcinoma of esophagus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1050045C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1114422C (en) * | 2000-03-13 | 2003-07-16 | 徐忠廷 | Anti-cancer Chinese-medicinal pill |
| CN102406841A (en) * | 2011-12-02 | 2012-04-11 | 龚定军 | Traditional Chinese medicine for treating tumor |
| CN102416083A (en) * | 2011-12-12 | 2012-04-18 | 许从玉 | A kind of pharmaceutical composition for treating esophageal cancer |
| CN101347459B (en) * | 2008-09-10 | 2013-01-02 | 刘皇琼 | Medicine for treating cancer |
-
1993
- 1993-04-17 CN CN93104343A patent/CN1050045C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1114422C (en) * | 2000-03-13 | 2003-07-16 | 徐忠廷 | Anti-cancer Chinese-medicinal pill |
| CN101347459B (en) * | 2008-09-10 | 2013-01-02 | 刘皇琼 | Medicine for treating cancer |
| CN102406841A (en) * | 2011-12-02 | 2012-04-11 | 龚定军 | Traditional Chinese medicine for treating tumor |
| CN102416083A (en) * | 2011-12-12 | 2012-04-18 | 许从玉 | A kind of pharmaceutical composition for treating esophageal cancer |
| CN102416083B (en) * | 2011-12-12 | 2012-07-18 | 许从玉 | Medicinal composition for treating esophagus cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1050045C (en) | 2000-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1210047C (en) | Medicine for treating cold and preparation method thereof | |
| CN100382839C (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN1050045C (en) | Traditional Chinese medicine-Liu's Hua'ai huixiangdan for treating carcinoma of esophagus | |
| CN1507884A (en) | Traditional Chinese medicine powder and decoction composition for treating cancer | |
| CN1056755C (en) | Medicine of curing hepatitis | |
| CN100411666C (en) | Broad-specturm medicine for treating snake venom poisoning | |
| CN1255150C (en) | Chinese medicine preparation for curing hyperosteogeny and its preparation method | |
| CN1302799C (en) | Oral Chinese medicinal composition for treating virus myocarditis | |
| CN1616041A (en) | Chinese medicine composition for treating chronic ulcerative colitis | |
| CN1313138C (en) | Chinese medicine preparation treating Parkinson's syndrome | |
| CN1055014C (en) | Medicine powder for curing hepatitis B | |
| CN106344680B (en) | A kind of Chinese medicine composition with wind and relieving paralysis effect of dispelling and preparation method thereof | |
| CN1537559A (en) | Traditional Chinese medicine for treating AIDS | |
| CN1060048C (en) | Snake spirit for rheumatism and its preparation | |
| RU2133096C1 (en) | Biologically active food addition "pari" and method of its use | |
| CN1245184C (en) | A kind of traditional Chinese medicine preparation for treating insomnia and preparation method thereof | |
| CN101194997A (en) | Chinese medicine preparation for treating AIDS method for preparing the same | |
| CN1093421C (en) | Process for preparing snuff to treat hepatitis B | |
| CN1177592C (en) | Application of Radix Radix Radix Radix Extract Total Saponins in the Preparation of Drugs for Treating Myocarditis | |
| CN1824020A (en) | Medicine for treating coronary heart disease and preparation method thereof | |
| CN1292765C (en) | Pharmaceutical composition, its preparation process and usage | |
| CN1087612C (en) | Anti-cancer compound preparation | |
| CN1063074C (en) | Chinese herbs injection for treating oncoma (cancer) and preparation method | |
| CN1200289A (en) | Sanhua xietingye liquid medicine for treating diarrhea made of three flowers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |